{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:57:31Z","timestamp":1740146251314,"version":"3.37.3"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184322","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T13:38:27Z","timestamp":1505223507000},"page":"e0184322","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7272-3708","authenticated-orcid":true,"given":"Ippei","family":"Fukada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kokoro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Horii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Futoshi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1200\/JCO.2005.02.027","article-title":"Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer","volume":"23","author":"SE Jones","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"WJ Gradishar","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.2007.11.6699","article-title":"Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840","volume":"26","author":"AD Seidman","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer. American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"AC Wolff","year":"2014","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3892\/ol.2016.4627","article-title":"Therapeutic effect of taxanes on metastatic breast cancer of various immunohistochemical subtypes","volume":"12","author":"I Fukada","year":"2016","journal-title":"Oncol letters"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2008.01.008","article-title":"Peripheral nerve damage associated with administration of taxanes in patients with cancer","volume":"66","author":"AA Argyriou","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neuro.2013.05.008","article-title":"Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy","volume":"37","author":"NE LaPointe","year":"2013","journal-title":"Neurotoxicology"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.expneurol.2006.07.022","article-title":"Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells","volume":"203","author":"CM Peters","year":"2007","journal-title":"Exp Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.2011.39.8446","article-title":"Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxanecontaining therapy for operable breast cancer","volume":"30","author":"BP Schneider","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00280-014-2607-5","article-title":"Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer","volume":"75","author":"E Rivera","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl 4","key":"ref11","doi-asserted-by":"crossref","first-page":"iv45","DOI":"10.1093\/neuonc\/nos203","article-title":"Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention","volume":"14","author":"W Grisold","year":"2012","journal-title":"Neuro Oncol"},{"issue":"13","key":"ref12","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-05-0298","article-title":"Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer","volume":"11","author":"S Mielke","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref13","first-page":"4423","article-title":"Paclitaxel pharmacokinetics and response to chemotherapy in patients with advanced cancer treated with a weekly regimen","volume":"25","author":"S Mielke","year":"2005","journal-title":"Anticancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1200\/JCO.2015.66.2346","article-title":"Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials","volume":"34","author":"DL Hershman","year":"2016","journal-title":"J Clin Oncol"},{"issue":"22","key":"ref15","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-15-0586","article-title":"Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199","volume":"21","author":"BP Schneider","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"25","key":"ref16","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.2011.39.8446","article-title":"Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer","volume":"30","author":"BP Schneider","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref17","first-page":"4026","article-title":"Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme","volume":"54","author":"JW Harris","year":"1994","journal-title":"Cancer Res"},{"issue":"21","key":"ref18","first-page":"5543","article-title":"Selective biotransformation of taxol to 6 alphahydroxytaxol by human cytochrome P450 2C8","volume":"54","author":"A Rahman","year":"1994","journal-title":"Cancer Res"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00689197","article-title":"Comparative in vitro cytotoxic effects of taxol and its major human metabolite 6 alpha-hydroxytaxol","volume":"36","author":"G Kumar","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10549-012-2054-0","article-title":"CYP2C8*3 predicts benefit\/risk profile in breast cancer patients receiving neoadjuvant paclitaxel","volume":"134","author":"DL Hertz","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdt018","article-title":"CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel","volume":"24","author":"DL Hertz","year":"2013","journal-title":"Ann Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T07:16:41Z","timestamp":1570087001000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184322"}},"subtitle":[],"editor":[{"given":"William B.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184322","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,9,12]]}}}